Regeneron Pharmaceuticals (Q18201): Difference between revisions
Jump to navigation
Jump to search
Created claim: country (P90): United States of America (Q6617) |
Created claim: stock exchange (P574): Nasdaq (Q8874) |
||||||||||||||
| Property / stock exchange | |||||||||||||||
| Property / stock exchange: Nasdaq / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / stock exchange: Nasdaq / qualifier | |||||||||||||||
ticker symbol: REGN | |||||||||||||||
| Property / stock exchange: Nasdaq / qualifier | |||||||||||||||
start time: 2 April 1991
| |||||||||||||||
Revision as of 13:17, 3 January 2024
American pharmaceutical company
- Regeneron
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Regeneron Pharmaceuticals |
American pharmaceutical company |
|
Statements
1988
0 references